JP Morgan's Friday Blitz: Winners and Losers

JP Morgan dominated the analyst tape on Friday, issuing a wave of target price changes across sectors.

The biggest upgrade in dollar terms went to COST. JP Morgan's Christopher Horvers lifted his target from $1,015 to $1,150, a $135 jump. The retailer commands a consensus of 26 buy ratings against just 2 sells.

FICO took the sharpest cut. Alexander Hess slashed his target from $900 to $800, a $100 drop, while keeping a Hold rating. The credit-scoring firm sits in a near-even split between buys and sells among analysts, suggesting the Street is divided.

Medical devices saw contrasting moves. Robbie Marcus raised his target on EW from $105 to $120 and kept a Buy. He also lifted PODD from $152 to $170, though that one remains a Hold. The divergence points to continued selectivity in the medtech space.

QCOM saw its target trimmed from $215 to $200. Samik Chatterjee at JP Morgan maintained a Hold on the chipmaker. With 23 Hold ratings against just 3 Buys and 11 Sells, consensus remains cautious on Qualcomm.

IFF drew attention from two separate firms. JP Morgan's Jeffrey Zekauskas raised his target to $95 from $92, while Citigroup's Patrick Cunningham pushed his to $105 from $100. Both carry Buy ratings. Dual upgrades on the same day are rare and signal growing confidence in the fragrance giant's recovery.

CDW got a target lift from $170 to $195. The IT solutions firm has 7 Buy ratings but only 3 Holds, making it one of the more bullish setups in the batch.